New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.
PsyPost on MSN2d
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linkedA Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...
According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
New research published in New England Journal of Medicine and presented at this year's Annual Meeting of the European ...
TAG24 NEWS on MSN10d
New diabetes jab taken once a week instead of once a dayFindings from two US trials of efsitora, developed by pharma company Eli Lilly, have been presented at the annual meeting of ...
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...
Do you ever feel confused about your diabetes? Learning when and what to eat, why your blood sugar is high or low, when or ...
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...
New research published in NEJM and presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid (9-13 Sept) shows that a new class of insulin that is ...
News Medical on MSN3d
Study links diabetes drugs to lower risk of dementia and Parkinson's diseaseA class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback